Terms: = Liver cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Prognosis
215 results:
1. Efficacy and safety of second-line therapy by S-1 combined with sintilimab and anlotinib in pancreatic cancer patients with liver metastasis: a single-arm, phase II clinical trial.
Qiu X; Lu C; Sha H; Zhu Y; Kong W; Tong F; Wang Q; Meng F; Liu B; Du J
Front Immunol; 2024; 15():1210859. PubMed ID: 38361920
[TBL] [Abstract] [Full Text] [Related]
2. Pan-cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours.
Chen Y; Gao Z; Mohd-Ibrahim I; Yang H; Wu L; Fu Y; Deng Y
Clin Transl Med; 2024 Feb; 14(2):e1543. PubMed ID: 38303608
[TBL] [Abstract] [Full Text] [Related]
3. [Prognostic factors in patients with hematological malignancies and concomitant chronic hepatitis C].
Nozhkin MS; Lioznov DA; Antonova TV; Gorchakova OV; Goldstein EM; Popova MO; Shneyder TV
Ter Arkh; 2023 Dec; 95(11):919-923. PubMed ID: 38158946
[TBL] [Abstract] [Full Text] [Related]
4. Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal cancer after Treatment Termination.
Simmons K; Thomas JV; Ludford K; Willis JA; Higbie VS; Raghav KPS; Johnson B; Dasari A; Kee BK; Parseghian CM; Lee MS; Le PH; Morelli MP; Shen JP; Bent A; Vilar E; Wolff RA; Kopetz S; Overman MJ; Morris VK
Cancer Res Commun; 2023 Dec; 3(12):2510-2517. PubMed ID: 38085001
[TBL] [Abstract] [Full Text] [Related]
5. Fifteen-year survival of a hepatocellular carcinoma extending into the right atrium treated by surgical resection with the heart-first approach under cardiopulmonary bypass: a case report and review of the literature.
Nishiwaki Y; Kusano T; Hiraiwa T; Ozawa T
Clin J Gastroenterol; 2024 Feb; 17(1):118-129. PubMed ID: 37904033
[TBL] [Abstract] [Full Text] [Related]
6. Hyperbilirubinemia in hospitalized patients: Etiology and outcomes.
Kwon JY; Nietert PJ; Rockey DC
J Investig Med; 2023 Oct; 71(7):773-781. PubMed ID: 37386866
[TBL] [Abstract] [Full Text] [Related]
7. Immuno-PET of colorectal cancer with a CEA-targeted [68 Ga]Ga-nanobody: from bench to bedside.
Li L; Lin X; Wang L; Ma X; Zeng Z; Liu F; Jia B; Zhu H; Wu A; Yang Z
Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3735-3749. PubMed ID: 37382662
[TBL] [Abstract] [Full Text] [Related]
8. Qualitative evaluation of barriers and facilitators to hepatocellular carcinoma care in North Carolina.
Ray EM; Teal RW; Carda-Auten J; Coffman E; Sanoff HK
PLoS One; 2023; 18(6):e0287338. PubMed ID: 37347754
[TBL] [Abstract] [Full Text] [Related]
9. AFP-L3 and DCP are superior to AFP in predicting waitlist dropout in HCC patients: Results of a prospective study.
Mehta N; Kotwani P; Norman J; Shui A; Li PJ; Saxena V; Chan W; Yao FY
Liver Transpl; 2023 Oct; 29(10):1041-1049. PubMed ID: 37159217
[TBL] [Abstract] [Full Text] [Related]
10. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.
Kelley RK; Ueno M; Yoo C; Finn RS; Furuse J; Ren Z; Yau T; Klümpen HJ; Chan SL; Ozaka M; Verslype C; Bouattour M; Park JO; Barajas O; Pelzer U; Valle JW; Yu L; Malhotra U; Siegel AB; Edeline J; Vogel A;
Lancet; 2023 Jun; 401(10391):1853-1865. PubMed ID: 37075781
[TBL] [Abstract] [Full Text] [Related]
11. Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma.
Spencer K; Pappas L; Baiev I; Maurer J; Bocobo AG; Zhang K; Jain A; De Armas AD; Reyes S; Le TM; Rahma OE; Stanton J; DeLeon TT; Roth M; Peters MLB; Zhu AX; Lennerz JK; Iafrate AJ; Boyhen K; VanCott C; Roberts LR; Lindsey S; Horick N; Goff LW; Mody K; Borad MJ; Shroff RT; Kelley RK; Javle MM; Goyal L
J Natl Cancer Inst; 2023 Jul; 115(7):870-880. PubMed ID: 37040087
[TBL] [Abstract] [Full Text] [Related]
12. CS-iCCA, A New Clinically Based Staging System for Intrahepatic Cholangiocarcinoma: Establishment and External Validation.
Lozada ME; Zhang N; Jin W; Wongjarupong N; Yang JD; Voss MM; Prasai K; Amakye DO; Harmsen WS; Chaudhary S; Bathe OF; Borad MJ; Patel TC; Gores GJ; Therneau TM; Roberts LR
Am J Gastroenterol; 2023 Dec; 118(12):2173-2183. PubMed ID: 36940423
[TBL] [Abstract] [Full Text] [Related]
13. Effectiveness and tolerability of camrelizumab combined with molecular targeted therapy for patients with unresectable or advanced HCC.
Li T; Guo J; Liu Y; Du Z; Guo Z; Fan Y; Cheng L; Zhang Y; Gao X; Zhao Y; He X; Wu W; Gao N; Wu Y; Li J; Zhang Y; Kang W; Cai Z; Wang W; Li X; Zan Y; Nguyen MH; Ji F
Cancer Immunol Immunother; 2023 Jul; 72(7):2137-2149. PubMed ID: 36840762
[TBL] [Abstract] [Full Text] [Related]
14. Demystifying BRAF Mutation Status in Colorectal liver Metastases : A Multi-institutional, Collaborative Approach to 6 Open Clinical Questions.
Margonis GA; Boerner T; Bachet JB; Buettner S; Moretto R; Andreatos N; Sartore-Bianchi A; Wang J; Kamphues C; Gagniere J; Lonardi S; Løes IM; Wagner D; Spallanzani A; Sasaki K; Burkhart R; Pietrantonio F; Pikoulis E; Pawlik TM; Truant S; Orlandi A; Pikouli A; Pella N; Beyer K; Poultsides G; Seeliger H; Aucejo FN; Kornprat P; Kaczirek K; Lønning PE; Kreis ME; Wolfgang CL; Weiss MJ; Cremolini C; Benoist S; D'Angelica M
Ann Surg; 2023 Sep; 278(3):e540-e548. PubMed ID: 36453261
[TBL] [Abstract] [Full Text] [Related]
15. All-cause and liver-related mortality risk factors in excessive drinkers: Analysis of data from the UK biobank.
Whitfield JB; Seth D; Morgan TR;
Alcohol Clin Exp Res; 2022 Dec; 46(12):2245-2257. PubMed ID: 36317527
[TBL] [Abstract] [Full Text] [Related]
16. Dynamic CT and Gadoxetic Acid-enhanced MRI Characteristics of P53-mutated Hepatocellular Carcinoma.
Kitao A; Matsui O; Zhang Y; Ogi T; Nakada S; Sato Y; Harada K; Yoneda N; Kozaka K; Inoue D; Yoshida K; Koda W; Yamashita T; Yamashita T; Kaneko S; Kobayashi S; Gabata T
Radiology; 2023 Feb; 306(2):e220531. PubMed ID: 36219111
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry.
Metzenmacher M; Griesinger F; Hummel HD; Elender C; Schäfer H; de Wit M; Kaiser U; Kern J; Jänicke M; Spring L; Zacharias S; Kaiser-Osterhues A; Groth A; Hipper A; Zaun G; Dörfel S; Güldenzoph B; Müller L; Uhlig J; Thomas M; Sebastian M; Eberhardt WEE;
Eur Respir J; 2023 Feb; 61(2):. PubMed ID: 36180086
[TBL] [Abstract] [Full Text] [Related]
18. Natural Language Processing of Computed Tomography Reports to Label Metastatic Phenotypes With Prognostic Significance in Patients With Colorectal cancer.
Causa Andrieu P; Golia Pernicka JS; Yaeger R; Lupton K; Batch K; Zulkernine F; Simpson AL; Taya M; Gazit L; Nguyen H; Nicholas K; Gangai N; Sevilimedu V; Dickinson S; Paroder V; Bates DDB; Do R
JCO Clin Cancer Inform; 2022 Sep; 6():e2200014. PubMed ID: 36103642
[TBL] [Abstract] [Full Text] [Related]
19. liver and spleen volumes are associated with prognosis of compensated and decompensated cirrhosis and parallel its natural history.
Romero-Cristóbal M; Clemente-Sánchez A; Peligros MI; Ramón E; Matilla AM; Colón A; Alonso S; Catalina MV; Fernández-Yunquera A; Caballero A; García R; López-Baena JÁ; Salcedo MM; Bañares R; Rincón D
United European Gastroenterol J; 2022 Oct; 10(8):805-816. PubMed ID: 36065767
[TBL] [Abstract] [Full Text] [Related]
20. The Multifaceted Role of Aquaporin-9 in Health and Its Potential as a Clinical Biomarker.
da Silva IV; Garra S; Calamita G; Soveral G
Biomolecules; 2022 Jun; 12(7):. PubMed ID: 35883453
[TBL] [Abstract] [Full Text] [Related]
[Next]
